Penumbra (PEN) Non-Current Assets (2014 - 2026)
Penumbra's (PEN) quarterly Non-Current Assets came in at $623.0 million in Q1 2026, up 4.96% year-on-year from $593.6 million in Q1 2025, and up 2.16% on a QoQ basis from $609.8 million in Q4 2025.
Penumbra (PEN) Non-Current Assets (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Non-Current Assets data on file, last reported at $623.0 million in Q1 2026.
- On a quarterly basis, Non-Current Assets rose 4.96% year-over-year to $623.0 million in Q1 2026; TTM through Mar 2026 was $2.4 billion, a 3.88% increase from a year earlier, with the FY2025 full-year figure at $609.8 million, up 4.77% from the prior year.
- Non-Current Assets for Q1 2026 stood at $623.0 million, up from $609.8 million in the prior quarter.
- Over the last five years, Non-Current Assets for PEN reached as high as $644.8 million in Q1 2024 and fell as low as $582.1 million in Q4 2024.
- Historically, Non-Current Assets has averaged $607.8 million across 5 years, with a median of $608.8 million in 2023.
- Across the five-year window, Non-Current Assets soared 197.16% in 2022 and declined 9.18% in 2024, its largest moves.
- Year by year, Non-Current Assets stood at $615.2 million in 2022, then rose by 4.18% to $640.9 million in 2023, then dropped by 9.18% to $582.1 million in 2024, then rose by 4.77% to $609.8 million in 2025, then gained by 2.16% to $623.0 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $623.0 million in Q1 2026, $609.8 million in Q4 2025, and $602.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 623.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 623.03 Mn |
| Dec 31, 2025 | 609.84 Mn |
| Sep 30, 2025 | 602.85 Mn |
| Jun 30, 2025 | 609.33 Mn |
| Mar 31, 2025 | 593.60 Mn |
| Dec 31, 2024 | 582.06 Mn |
| Sep 30, 2024 | 587.37 Mn |
| Jun 30, 2024 | 590.77 Mn |
| Mar 31, 2024 | 644.82 Mn |
| Dec 31, 2023 | 640.90 Mn |
| Sep 30, 2023 | 599.90 Mn |
| Jun 30, 2023 | 604.66 Mn |
| Mar 31, 2023 | 608.81 Mn |
| Dec 31, 2022 | 615.19 Mn |
| Sep 30, 2022 | 597.98 Mn |
| Jun 30, 2022 | 609.94 Mn |
| Mar 31, 2022 | 611.25 Mn |
| Dec 31, 2021 | 562.78 Mn |
| Sep 30, 2021 | 305.25 Mn |
| Mar 31, 2021 | 205.70 Mn |